A previous pre-clinical model study demonstrated that olanzapine caused significant glucose intolerance and more insulin resistance incidences in the hyperinsulinaemic-euglycemic clamp test; this laboratory method was used as a standardized test in evaluating insulin sensitivity in type 2 diabetes mellitus patients [1,36]. Here, INS is linked to diabetes mellitus.